Gene overview
| Strategies/Algorithm: | overlap | Ensembl ID: | ENSG00000283591 |
| Gene: | MIR4430 | Gene type: | miRNA |
| Strand: | + | External links: |
|
| Genomic region: | chr2:33418516-33418564 | Genome Browser: |   |
Super-enhancer search result of gene-based
| SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SE_02_044200406 | chr2:33389435-33443639 |
Sample_02_0442 | Bone | MG63.3 | 406 | 29 | 1930 | 36 | 2 | 96 | 226 | LTBP1,MIR4430,RASGRP3 |
| SE_01_011100537 | chr2:33390790-33449380 |
Sample_01_0111 | Brain | SK-N-SH | 537 | 20 | 2027 | 43 | 2 | 100 | 264 | LTBP1,MIR4430,RASGRP3 |
| SE_02_126601217 | chr2:33406754-33438391 |
Sample_02_1266 | Bone | Im-GCT-4072_G34W-repair_WT_E3 | 1217 | 10 | 1143 | 23 | 1 | 39 | 46 | MIR4430,RASGRP3 |
| SE_02_150500128 | chr2:33412108-33440143 |
Sample_02_1505 | Brain | SHEP with tetracycline inducible MYC_DOX_2HR | 128 | 13 | 1012 | 22 | 1 | 42 | 46 | MIR4430,RASGRP3 |
| SE_02_150400119 | chr2:33412128-33439581 |
Sample_02_1504 | Brain | SHEP with tetracycline inducible MYCN_0HR | 119 | 10 | 993 | 22 | 1 | 41 | 46 | MIR4430,RASGRP3 |
| SE_02_150600140 | chr2:33412146-33441330 |
Sample_02_1506 | Brain | SHEP with tetracycline inducible MYC_DOX_6HR | 140 | 15 | 1038 | 22 | 1 | 42 | 46 | MIR4430,RASGRP3 |
| SE_02_045100768 | chr2:33412243-33440100 |
Sample_02_0451 | Skin | in vitro transformedskin fibroblasts_tumourigenic | 768 | 9 | 1006 | 22 | 1 | 41 | 46 | MIR4430,RASGRP3 |
| SE_02_143700588 | chr2:33412619-33442443 |
Sample_02_1437 | Liver | LSEC-TNF | 588 | 9 | 1054 | 22 | 1 | 43 | 46 | MIR4430,RASGRP3 |
| SE_02_057900458 | chr2:33412702-33448650 |
Sample_02_0579 | Blood | HEL_sgNeg2 | 458 | 15 | 1215 | 27 | 1 | 77 | 92 | MIR4430,RASGRP3 |
| SE_02_058000669 | chr2:33412725-33448741 |
Sample_02_0580 | Blood | HEL_sgSIK3e4 | 669 | 11 | 1212 | 27 | 1 | 77 | 92 | MIR4430,RASGRP3 |
| SE_02_143800543 | chr2:33412780-33441230 |
Sample_02_1438 | Liver | LSEC | 543 | 6 | 1009 | 22 | 1 | 42 | 46 | MIR4430,RASGRP3 |
| SE_02_057600551 | chr2:33412781-33448735 |
Sample_02_0576 | Blood | HEL_sgLKB1e2 | 551 | 14 | 1209 | 27 | 1 | 77 | 92 | MIR4430,RASGRP3 |
| SE_02_143600513 | chr2:33413265-33442684 |
Sample_02_1436 | Liver | LSEC-Ctrl | 513 | 12 | 1035 | 22 | 1 | 54 | 46 | MIR4430,RASGRP3 |
| SE_02_045200800 | chr2:33413790-33439809 |
Sample_02_0452 | Skin | hTERT immortalised human skin fibroblasts_Non-tumourigenic | 800 | 9 | 935 | 21 | 1 | 39 | 46 | MIR4430,RASGRP3 |
| SE_02_139000726 | chr2:33414516-33425712 |
Sample_02_1390 | Peripheral blood | SU-DHL-1_ALK+ | 726 | 3 | 395 | 10 | 0 | 2 | 0 | MIR4430,RASGRP3 |
Genomic distribution of SEs associated with MIR4430